You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Synthetic biologists are developing an attenuated version of SARS-CoV-2 for use in a vaccine, Technology Review reports. It adds that Codagenix is working with the Serum Institute of India, a large vaccine maker.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.
Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.
A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.
In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.